1. Home
  2. VSH vs WVE Comparison

VSH vs WVE Comparison

Compare VSH & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSH
  • WVE
  • Stock Information
  • Founded
  • VSH 1962
  • WVE 2012
  • Country
  • VSH United States
  • WVE Singapore
  • Employees
  • VSH N/A
  • WVE N/A
  • Industry
  • VSH Electrical Products
  • WVE Biotechnology: Pharmaceutical Preparations
  • Sector
  • VSH Technology
  • WVE Health Care
  • Exchange
  • VSH Nasdaq
  • WVE Nasdaq
  • Market Cap
  • VSH 2.4B
  • WVE 2.4B
  • IPO Year
  • VSH N/A
  • WVE 2015
  • Fundamental
  • Price
  • VSH $15.50
  • WVE $14.35
  • Analyst Decision
  • VSH Buy
  • WVE Strong Buy
  • Analyst Count
  • VSH 2
  • WVE 10
  • Target Price
  • VSH $23.50
  • WVE $21.30
  • AVG Volume (30 Days)
  • VSH 1.5M
  • WVE 1.3M
  • Earning Date
  • VSH 11-06-2024
  • WVE 11-12-2024
  • Dividend Yield
  • VSH 2.57%
  • WVE N/A
  • EPS Growth
  • VSH N/A
  • WVE N/A
  • EPS
  • VSH 0.62
  • WVE N/A
  • Revenue
  • VSH $3,008,107,000.00
  • WVE $53,610,000.00
  • Revenue This Year
  • VSH N/A
  • WVE N/A
  • Revenue Next Year
  • VSH $5.14
  • WVE N/A
  • P/E Ratio
  • VSH $25.01
  • WVE N/A
  • Revenue Growth
  • VSH N/A
  • WVE N/A
  • 52 Week Low
  • VSH $14.95
  • WVE $3.50
  • 52 Week High
  • VSH $24.72
  • WVE $16.74
  • Technical
  • Relative Strength Index (RSI)
  • VSH 31.98
  • WVE 54.93
  • Support Level
  • VSH $14.95
  • WVE $12.66
  • Resistance Level
  • VSH $18.02
  • WVE $16.71
  • Average True Range (ATR)
  • VSH 0.53
  • WVE 1.14
  • MACD
  • VSH -0.17
  • WVE -0.36
  • Stochastic Oscillator
  • VSH 15.18
  • WVE 41.42

About VSH Vishay Intertechnology Inc.

Vishay Intertechnology Inc provides a broad product portfolio of discrete semiconductors and passive electronic components to original equipment manufacturers and distributors. These products are found in industrial, computing, automotive, consumer, telecommunications, power supplies, military, aerospace, and medical markets and serve customer worldwide. Its product segments consist of two general classes: semiconductors and passive components. The company's operating segment includes metal oxide semiconductor field-effect transistors, diodes, optoelectronic components, resistors, inductors, and capacitors. Revenue mainly comes from resistors, which are basic components used in all forms of electronic circuitry to adjust and regulate levels of voltage and current.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is unlocking the broad potential of RNA medicines also known as oligonucleotides, it targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISMTM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, splicing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: